Analog Device
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Analog Device sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Analog Device: 5 sponsored US clinical trials, 1 recruiting.
Analog Device sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cardiopulmonary Disease, with 1 trials.
Upper-quartile sponsor footprint
Analog Device sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NCT05650541
ECG Validation Study
NCT05445726
Respiration Validation for CPM Device
NCT05445492
Clinical Validation Study for CPM Device
NCT05445206
Clinical Validation Study for Noninvasive Cardiopulmonary Management Device
NCT04865640
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Analog Device pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Cardiopulmonary Disease (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Analog Device: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Analog Device sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Analog Device page
5 registered trials is a research-attention snapshot, not an endorsement of Analog Device or any single study.
- 1 of Analog Device's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cardiopulmonary Disease is the condition Analog Device studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiopulmonary Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Analog Device pipeline card: 5 registered trials from official public datasets.Report a data error.